Deep Learning‐Based Techniques in Glioma Brain Tumor Segmentation Using Multi‐Parametric MRI: A Review on Clinical Applications and Future Outlooks

Author:

Ghadimi Delaram J.1ORCID,Vahdani Amir M.2ORCID,Karimi Hanie3,Ebrahimi Pouya4,Fathi Mobina1,Moodi Farzan56,Habibzadeh Adrina7,Khodadadi Shoushtari Fereshteh6,Valizadeh Gelareh6,Mobarak Salari Hanieh6,Saligheh Rad Hamidreza68ORCID

Affiliation:

1. School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

2. Image Guided Surgery Lab, Research Center for Biomedical Technologies and Robotics, Advanced Medical Technologies and Equipment Institute, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran Iran

3. School of Medicine Tehran University of Medical Sciences Tehran Iran

4. Tehran Heart Center, Cardiovascular Diseases Research Institute Tehran University of Medical Sciences Tehran Iran

5. School of Medicine Iran University of Medical Sciences Tehran Iran

6. Quantitative MR Imaging and Spectroscopy Group (QMISG) Tehran University of Medical Sciences Tehran Iran

7. Student Research Committee Fasa University of Medical Sciences Fasa Iran

8. Department of Medical Physics and Biomedical Engineering Tehran University of Medical Sciences Tehran Iran

Abstract

This comprehensive review explores the role of deep learning (DL) in glioma segmentation using multiparametric magnetic resonance imaging (MRI) data. The study surveys advanced techniques such as multiparametric MRI for capturing the complex nature of gliomas. It delves into the integration of DL with MRI, focusing on convolutional neural networks (CNNs) and their remarkable capabilities in tumor segmentation. Clinical applications of DL‐based segmentation are highlighted, including treatment planning, monitoring treatment response, and distinguishing between tumor progression and pseudo‐progression. Furthermore, the review examines the evolution of DL‐based segmentation studies, from early CNN models to recent advancements such as attention mechanisms and transformer models. Challenges in data quality, gradient vanishing, and model interpretability are discussed. The review concludes with insights into future research directions, emphasizing the importance of addressing tumor heterogeneity, integrating genomic data, and ensuring responsible deployment of DL‐driven healthcare technologies.Evidence LevelN/ATechnical EfficacyStage 2

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3